Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
30
CASBF Quote, Financials, Valuation and Earnings
Last price:
$4.28
Seasonality move
:
19.62%
Day range:
$4.28 - $4.28
52-week range:
$3.20 - $6.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.87x
P/B ratio:
1.53x
Volume:
--
Avg. volume:
2K
1-year change:
3.69%
Market cap:
$1.1B
Revenue:
$116.2M
EPS (TTM):
-$0.08
Earnings Data
Next earnings date for CASBF
Mar 25
2026
Most recent earnings per share
$0.02
Beat by $0.02
(Oct 27/2025)
Consensus Estimate
--
(Oct 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CASBF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/27/2025 | Q3 | -- | $43.3M | $0.02 | -- | -- |
| 08/20/2025 | Q2 | -- | $33.9M | -$0.00 | -- | -- |
| 04/29/2025 | Q1 | -- | $18.8M | -$0.01 | -- | -- |
| 12/31/2024 | Q4 | -- | $38.4M | -$0.09 | -- | -- |
| 09/30/2024 | Q3 | -- | $36.4M | -- | -- | -- |
| 08/29/2024 | Q2 | -- | $23.8M | -$0.03 | -- | -- |
| 04/30/2024 | Q1 | -- | $16M | -$0.10 | -- | -- |
| 12/31/2023 | Q4 | -- | $23.6M | -$0.28 | -- | -- |
| 10/31/2023 | Q3 | -- | -- | -$0.08 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.41 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.08 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.25 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.29 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.05 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.05 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.04 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.02 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.01 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.04 | -- | -- |
CanSino Biologics, Inc. Earnings Questions
-
How Much did CanSino Biologics, Inc. Generate in Revenue Last Quarter?
CanSino Biologics, Inc. reported $43.3M worth of top line sales in its most recent quarter.
-
Did CanSino Biologics, Inc. Beat Earnings Last Quarter?
CanSino Biologics, Inc. announced earnings per share of $0.02 which represents a beat of analyst forecast a -- per share.
-
Is CanSino Biologics, Inc. Profitable?
CanSino Biologics, Inc. reported $34M that represents $0.14 per share over the last quarter.
-
What is the Analyst Consensus for CanSino Biologics, Inc. EPS Next Year?
CanSino Biologics, Inc.'s earnings are forecast to grow from -$0.21 per share to -- per share next year representing an increase of --.
-
When is CanSino Biologics, Inc.'s Earnings Date?
CanSino Biologics, Inc.'s next earnings date is March 25, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 5.38% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is up 1.37% over the past day.
Buy
69
QBTS alert for Dec 23
D-Wave Quantum, Inc. [QBTS] is down 3.36% over the past day.
